Analysis Zenlabs Ethica Limited (ZENLABS)
6/2/2024
Analysis of Zenlabs Ethica Limited (ZENLABS)
Zenlabs Ethica Limited (ZENLABS) has shown some interesting price movements and technical indicators in the recent days:1. Price Movement:
- The stock price closed at 47.93 on the most recent trading day, showing a slight decrease from the previous day's close of 48.41.
- The price has been fluctuating between a low of 45.70 and a high of 48.50, indicating some volatility in the stock.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) is currently at 60.47, suggesting that the stock is neither overbought nor oversold.
- MACD Indicator: The MACD line is below the signal line, with a negative value of -0.25, indicating a potential bearish signal.
- Moving Averages: The Simple Moving Average (SMA) is at 45.30, the Exponential Moving Average (EMA) is at 44.16, and the Weighted Moving Average (WMA) is at 44.60. These moving averages can be used to identify trends in the stock price.
Overall, Zenlabs Ethica Limited seems to be trading in a range with some volatility. Traders and investors may want to monitor the technical indicators closely for potential trading opportunities.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has a strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a decrease in quarterly revenue and earnings growth year over year.
Moving on to stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has a beta of 1.264 and has shown a slight increase in the fifty-two week period.
Valuation metrics show a high PEG ratio and price to book ratio, with a relatively high forward PE ratio. The company's market capitalization and enterprise value are substantial, with moderate ratios for enterprise to EBITDA and enterprise to revenue.
Lastly, dividends and splits information reveals a low payout ratio, with upcoming dividend and ex-dividend dates. The company has a history of dividends and splits, with a relatively low dividend yield compared to the industry average.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe the following trends:
1. The company has experienced consistent revenue growth from 2020 to 2022, with a slight decrease in 2023.
2. Despite the decrease in 2023, the revenue figures are still higher compared to the initial year, indicating overall growth over the four-year period.
3. It would be beneficial to analyze the reasons behind the slight decrease in revenue in 2023 to understand the factors influencing this change and to develop strategies for future growth.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, long-term debt issuance, and short-term debt issuance.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.23
- Low Estimate: $1.18
- High Estimate: $1.26
- Year Ago EPS: $1.17
- Number of Analysts: 27
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.42
- Low Estimate: $1.33
- High Estimate: $1.51
- Year Ago EPS: $1.35
- Number of Analysts: 26
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.10
- Low Estimate: $5.95
- High Estimate: $6.41
- Year Ago EPS: $5.67
- Number of Analysts: 40
4. Next Year (as of September 30, 2025):
- Average Estimate: $6.69
- Low Estimate: $5.92
- High Estimate: $7.31
- Year Ago EPS: $6.10
- Number of Analysts: 40
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and years, with an increase compared to the previous year's EPS. This indicates potential growth and improvement in the company's financial performance according to analysts' projections.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, the following conclusions can be drawn:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates indicate a generally positive outlook for the company's sales performance, with expected growth in both the quarterly and annual sales figures over the coming quarters and years.
Growth estimates
Based on the consensus estimates provided:- The company is expected to experience a growth rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to have a compound annual growth rate (CAGR) of approximately 9.7%.
- However, when looking at the past 5 years, the company has had a higher historical CAGR of about 20.1%.
Overall, it appears that analysts are optimistic about the company's future growth prospects, with expectations of steady growth in the coming years compared to the higher growth rate seen in the past.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57. It appears that the analysts are generally optimistic about the future price of the security, with the average and median estimates both higher than the current price.MACD of ZENLABS
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
